The field of Alzheimer’s research has been dominated — and divided — by a hypothesis holding that toxic clumps in the brain are the main driver of the disease and that removing them will slow cognitive decline.
The controversial approval of an Alzheimer’s drug reignites the battle over the underlying cause of the disease
